A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy

[1]  F. Tinahones,et al.  Differential effects of restrictive and malabsorptive bariatric surgery procedures on the serum lipidome in obese subjects. , 2018, Journal of clinical lipidology.

[2]  K. Cusi,et al.  Use of a metabolomic approach to non‐invasively diagnose non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus , 2018, Diabetes, obesity & metabolism.

[3]  Shelly C. Lu,et al.  Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts , 2018, Hepatology communications.

[4]  T. Inge,et al.  Effect of bariatric surgery on urinary sphingolipids in adolescents with severe obesity. , 2017, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[5]  L. Henry,et al.  NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .

[6]  Marek Krawczyk,et al.  Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial , 2017, Annals of surgery.

[7]  R. Cohen,et al.  The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement , 2017, Current Atherosclerosis Reports.

[8]  X. Forns,et al.  A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients , 2017, Scientific Reports.

[9]  Jaehoon Lee,et al.  Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. , 2017, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[10]  M. Hussain,et al.  Sphingolipids and Lipoproteins in Health and Metabolic Disorders , 2017, Trends in Endocrinology & Metabolism.

[11]  Shelly C. Lu,et al.  Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis. , 2017, Gastroenterology.

[12]  D. Samuel,et al.  Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients , 2017, Scientific Reports.

[13]  J. Chhatwal,et al.  Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost‐effectiveness analysis , 2017, Hepatology.

[14]  M. Orešič,et al.  Sphingolipids and glycerophospholipids - The "ying and yang" of lipotoxicity in metabolic diseases. , 2017, Progress in lipid research.

[15]  E. Prifti,et al.  Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss , 2017, International Journal of Obesity.

[16]  J. Bertrand-Michel,et al.  Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models , 2016, Scientific Reports.

[17]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[18]  David S. Wishart,et al.  Heatmapper: web-enabled heat mapping for all , 2016, Nucleic Acids Res..

[19]  Ibon Martínez-Arranz,et al.  Enhancing metabolomics research through data mining. , 2015, Journal of proteomics.

[20]  Kosuke Saito,et al.  Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis , 2015, Scientific Reports.

[21]  F. Pattou,et al.  Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. , 2015, Gastroenterology.

[22]  F. Bäckhed,et al.  Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission , 2015, PloS one.

[23]  K. Clément,et al.  Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity. , 2015, Journal of hepatology.

[24]  J. Licinio,et al.  Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes , 2013, The Pharmacogenomics Journal.

[25]  Juan Antonio Vizcaíno,et al.  Shorthand notation for lipid structures derived from mass spectrometry , 2013, Journal of Lipid Research.

[26]  J. Kirwan,et al.  Role of ceramides in nonalcoholic fatty liver disease , 2012, Trends in Endocrinology & Metabolism.

[27]  Shelly C. Lu,et al.  Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. , 2012, Journal of proteome research.

[28]  Eoin Fahy,et al.  Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.

[29]  Shelly C. Lu,et al.  Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. , 2010, Journal of proteome research.

[30]  M. Orešič,et al.  Comparison of Lipid and Fatty Acid Composition of the Liver, Subcutaneous and Intra‐abdominal Adipose Tissue, and Serum , 2010, Obesity.

[31]  Michelle M Wiest,et al.  The plasma lipidomic signature of nonalcoholic steatohepatitis , 2009, Hepatology.

[32]  Michelle M Wiest,et al.  A lipidomic analysis of nonalcoholic fatty liver disease , 2007, Hepatology.

[33]  H. Cortez‐Pinto,et al.  Hepatic histology in obese patients undergoing bariatric surgery. , 2006, Journal of hepatology.